nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CHRM3—ureter—urinary bladder cancer	0.0802	0.339	CbGeAlD
Atropine—CHRM3—muscle of abdomen—urinary bladder cancer	0.0577	0.244	CbGeAlD
Atropine—CYP1A2—urine—urinary bladder cancer	0.0198	0.0837	CbGeAlD
Atropine—CHRM5—epithelium—urinary bladder cancer	0.0123	0.052	CbGeAlD
Atropine—CHRM2—prostate gland—urinary bladder cancer	0.0115	0.0486	CbGeAlD
Atropine—CHRM1—prostate gland—urinary bladder cancer	0.0105	0.0442	CbGeAlD
Atropine—CHRM3—prostate gland—urinary bladder cancer	0.00936	0.0396	CbGeAlD
Atropine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00662	0.028	CbGeAlD
Atropine—CHRM3—renal system—urinary bladder cancer	0.00638	0.027	CbGeAlD
Atropine—CHRM3—urethra—urinary bladder cancer	0.00626	0.0265	CbGeAlD
Atropine—CHRM1—female reproductive system—urinary bladder cancer	0.00571	0.0242	CbGeAlD
Atropine—CHRM3—female reproductive system—urinary bladder cancer	0.00511	0.0216	CbGeAlD
Atropine—CYP1A2—renal system—urinary bladder cancer	0.00484	0.0205	CbGeAlD
Atropine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000881	0.00115	CcSEcCtD
Atropine—Oedema—Cisplatin—urinary bladder cancer	0.000881	0.00115	CcSEcCtD
Atropine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000876	0.00115	CcSEcCtD
Atropine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000873	0.00114	CcSEcCtD
Atropine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00087	0.00114	CcSEcCtD
Atropine—Lethargy—Doxorubicin—urinary bladder cancer	0.00087	0.00114	CcSEcCtD
Atropine—Hypotension—Fluorouracil—urinary bladder cancer	0.000869	0.00114	CcSEcCtD
Atropine—Ataxia—Epirubicin—urinary bladder cancer	0.000866	0.00113	CcSEcCtD
Atropine—Tachycardia—Cisplatin—urinary bladder cancer	0.00086	0.00113	CcSEcCtD
Atropine—Convulsion—Etoposide—urinary bladder cancer	0.000857	0.00112	CcSEcCtD
Atropine—Dehydration—Epirubicin—urinary bladder cancer	0.000856	0.00112	CcSEcCtD
Atropine—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000856	0.00112	CcSEcCtD
Atropine—Insomnia—Gemcitabine—urinary bladder cancer	0.000855	0.00112	CcSEcCtD
Atropine—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000852	0.00112	CcSEcCtD
Atropine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000852	0.00112	CcSEcCtD
Atropine—Dry skin—Epirubicin—urinary bladder cancer	0.000844	0.00111	CcSEcCtD
Atropine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000843	0.0011	CcSEcCtD
Atropine—Chest pain—Etoposide—urinary bladder cancer	0.000842	0.0011	CcSEcCtD
Atropine—Insomnia—Fluorouracil—urinary bladder cancer	0.000841	0.0011	CcSEcCtD
Atropine—Somnolence—Gemcitabine—urinary bladder cancer	0.000841	0.0011	CcSEcCtD
Atropine—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000838	0.0011	CcSEcCtD
Atropine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000829	0.00109	CcSEcCtD
Atropine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000828	0.00108	CcSEcCtD
Atropine—Somnolence—Fluorouracil—urinary bladder cancer	0.000827	0.00108	CcSEcCtD
Atropine—Hypotension—Cisplatin—urinary bladder cancer	0.000824	0.00108	CcSEcCtD
Atropine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000818	0.00107	CcSEcCtD
Atropine—Fatigue—Gemcitabine—urinary bladder cancer	0.000815	0.00107	CcSEcCtD
Atropine—Confusional state—Etoposide—urinary bladder cancer	0.000814	0.00107	CcSEcCtD
Atropine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00081	0.00106	CcSEcCtD
Atropine—Pain—Gemcitabine—urinary bladder cancer	0.000809	0.00106	CcSEcCtD
Atropine—Constipation—Gemcitabine—urinary bladder cancer	0.000809	0.00106	CcSEcCtD
Atropine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000807	0.00106	CcSEcCtD
Atropine—Asthenia—Thiotepa—urinary bladder cancer	0.000807	0.00106	CcSEcCtD
Atropine—Abdominal distension—Epirubicin—urinary bladder cancer	0.000801	0.00105	CcSEcCtD
Atropine—Ataxia—Doxorubicin—urinary bladder cancer	0.000801	0.00105	CcSEcCtD
Atropine—Dysphagia—Epirubicin—urinary bladder cancer	0.000796	0.00104	CcSEcCtD
Atropine—Dysuria—Methotrexate—urinary bladder cancer	0.000795	0.00104	CcSEcCtD
Atropine—Pruritus—Thiotepa—urinary bladder cancer	0.000795	0.00104	CcSEcCtD
Atropine—Pain—Fluorouracil—urinary bladder cancer	0.000795	0.00104	CcSEcCtD
Atropine—Dehydration—Doxorubicin—urinary bladder cancer	0.000792	0.00104	CcSEcCtD
Atropine—Tachycardia—Etoposide—urinary bladder cancer	0.000788	0.00103	CcSEcCtD
Atropine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000786	0.00103	CcSEcCtD
Atropine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000783	0.00103	CcSEcCtD
Atropine—Dry skin—Doxorubicin—urinary bladder cancer	0.000781	0.00102	CcSEcCtD
Atropine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000781	0.00102	CcSEcCtD
Atropine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000779	0.00102	CcSEcCtD
Atropine—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000775	0.00102	CcSEcCtD
Atropine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000775	0.00102	CcSEcCtD
Atropine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000769	0.00101	CcSEcCtD
Atropine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000766	0.001	CcSEcCtD
Atropine—Drowsiness—Methotrexate—urinary bladder cancer	0.000758	0.000993	CcSEcCtD
Atropine—Depression—Methotrexate—urinary bladder cancer	0.000756	0.00099	CcSEcCtD
Atropine—Hypotension—Etoposide—urinary bladder cancer	0.000755	0.000988	CcSEcCtD
Atropine—Pain—Cisplatin—urinary bladder cancer	0.000754	0.000987	CcSEcCtD
Atropine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000748	0.000979	CcSEcCtD
Atropine—Dysuria—Epirubicin—urinary bladder cancer	0.000744	0.000975	CcSEcCtD
Atropine—Dizziness—Thiotepa—urinary bladder cancer	0.000743	0.000973	CcSEcCtD
Atropine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000741	0.000971	CcSEcCtD
Atropine—Urticaria—Fluorouracil—urinary bladder cancer	0.000739	0.000967	CcSEcCtD
Atropine—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000737	0.000965	CcSEcCtD
Atropine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000736	0.000964	CcSEcCtD
Atropine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000735	0.000962	CcSEcCtD
Atropine—Sweating—Methotrexate—urinary bladder cancer	0.000727	0.000952	CcSEcCtD
Atropine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000726	0.000951	CcSEcCtD
Atropine—Dyspnoea—Etoposide—urinary bladder cancer	0.00072	0.000943	CcSEcCtD
Atropine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000718	0.00094	CcSEcCtD
Atropine—Somnolence—Etoposide—urinary bladder cancer	0.000718	0.00094	CcSEcCtD
Atropine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000717	0.000939	CcSEcCtD
Atropine—Vomiting—Thiotepa—urinary bladder cancer	0.000715	0.000936	CcSEcCtD
Atropine—Drowsiness—Epirubicin—urinary bladder cancer	0.00071	0.000929	CcSEcCtD
Atropine—Rash—Thiotepa—urinary bladder cancer	0.000709	0.000928	CcSEcCtD
Atropine—Dermatitis—Thiotepa—urinary bladder cancer	0.000708	0.000927	CcSEcCtD
Atropine—Headache—Thiotepa—urinary bladder cancer	0.000704	0.000922	CcSEcCtD
Atropine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000697	0.000912	CcSEcCtD
Atropine—Fatigue—Etoposide—urinary bladder cancer	0.000696	0.000912	CcSEcCtD
Atropine—Pain—Etoposide—urinary bladder cancer	0.000691	0.000904	CcSEcCtD
Atropine—Constipation—Etoposide—urinary bladder cancer	0.000691	0.000904	CcSEcCtD
Atropine—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00069	0.000903	CcSEcCtD
Atropine—Dysuria—Doxorubicin—urinary bladder cancer	0.000689	0.000902	CcSEcCtD
Atropine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000685	0.000897	CcSEcCtD
Atropine—Sweating—Epirubicin—urinary bladder cancer	0.00068	0.000891	CcSEcCtD
Atropine—Asthenia—Gemcitabine—urinary bladder cancer	0.000678	0.000888	CcSEcCtD
Atropine—Pruritus—Gemcitabine—urinary bladder cancer	0.000669	0.000876	CcSEcCtD
Atropine—Nausea—Thiotepa—urinary bladder cancer	0.000668	0.000874	CcSEcCtD
Atropine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000665	0.000871	CcSEcCtD
Atropine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000664	0.00087	CcSEcCtD
Atropine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00066	0.000865	CcSEcCtD
Atropine—Pruritus—Fluorouracil—urinary bladder cancer	0.000658	0.000861	CcSEcCtD
Atropine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000657	0.00086	CcSEcCtD
Atropine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000649	0.00085	CcSEcCtD
Atropine—Bradycardia—Epirubicin—urinary bladder cancer	0.000649	0.000849	CcSEcCtD
Atropine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000647	0.000847	CcSEcCtD
Atropine—Urticaria—Etoposide—urinary bladder cancer	0.000641	0.00084	CcSEcCtD
Atropine—Abdominal pain—Etoposide—urinary bladder cancer	0.000638	0.000836	CcSEcCtD
Atropine—Body temperature increased—Etoposide—urinary bladder cancer	0.000638	0.000836	CcSEcCtD
Atropine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000638	0.000836	CcSEcCtD
Atropine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000636	0.000833	CcSEcCtD
Atropine—Asthenia—Cisplatin—urinary bladder cancer	0.000632	0.000828	CcSEcCtD
Atropine—Sweating—Doxorubicin—urinary bladder cancer	0.00063	0.000824	CcSEcCtD
Atropine—Dizziness—Fluorouracil—urinary bladder cancer	0.000615	0.000805	CcSEcCtD
Atropine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000603	0.00079	CcSEcCtD
Atropine—Vomiting—Gemcitabine—urinary bladder cancer	0.000601	0.000787	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—urinary bladder cancer	0.0006	0.000786	CcSEcCtD
Atropine—Mental disorder—Methotrexate—urinary bladder cancer	0.000596	0.000781	CcSEcCtD
Atropine—Rash—Gemcitabine—urinary bladder cancer	0.000596	0.000781	CcSEcCtD
Atropine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000596	0.00078	CcSEcCtD
Atropine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000595	0.000779	CcSEcCtD
Atropine—Erythema—Methotrexate—urinary bladder cancer	0.000593	0.000776	CcSEcCtD
Atropine—Headache—Gemcitabine—urinary bladder cancer	0.000592	0.000776	CcSEcCtD
Atropine—Flushing—Epirubicin—urinary bladder cancer	0.000591	0.000774	CcSEcCtD
Atropine—Vomiting—Fluorouracil—urinary bladder cancer	0.000591	0.000774	CcSEcCtD
Atropine—Rash—Fluorouracil—urinary bladder cancer	0.000586	0.000768	CcSEcCtD
Atropine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000586	0.000767	CcSEcCtD
Atropine—Headache—Fluorouracil—urinary bladder cancer	0.000582	0.000763	CcSEcCtD
Atropine—Dysgeusia—Methotrexate—urinary bladder cancer	0.00058	0.00076	CcSEcCtD
Atropine—Asthenia—Etoposide—urinary bladder cancer	0.000579	0.000759	CcSEcCtD
Atropine—Pruritus—Etoposide—urinary bladder cancer	0.000571	0.000748	CcSEcCtD
Atropine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000569	0.000745	CcSEcCtD
Atropine—Nausea—Gemcitabine—urinary bladder cancer	0.000562	0.000735	CcSEcCtD
Atropine—Vomiting—Cisplatin—urinary bladder cancer	0.00056	0.000734	CcSEcCtD
Atropine—Vision blurred—Methotrexate—urinary bladder cancer	0.000559	0.000731	CcSEcCtD
Atropine—Mental disorder—Epirubicin—urinary bladder cancer	0.000558	0.000731	CcSEcCtD
Atropine—Rash—Cisplatin—urinary bladder cancer	0.000556	0.000728	CcSEcCtD
Atropine—Dermatitis—Cisplatin—urinary bladder cancer	0.000555	0.000727	CcSEcCtD
Atropine—Erythema—Epirubicin—urinary bladder cancer	0.000555	0.000726	CcSEcCtD
Atropine—Diarrhoea—Etoposide—urinary bladder cancer	0.000552	0.000723	CcSEcCtD
Atropine—Nausea—Fluorouracil—urinary bladder cancer	0.000552	0.000723	CcSEcCtD
Atropine—Flushing—Doxorubicin—urinary bladder cancer	0.000547	0.000716	CcSEcCtD
Atropine—Tension—Epirubicin—urinary bladder cancer	0.000544	0.000713	CcSEcCtD
Atropine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000543	0.000711	CcSEcCtD
Atropine—Nervousness—Epirubicin—urinary bladder cancer	0.000539	0.000705	CcSEcCtD
Atropine—Dizziness—Etoposide—urinary bladder cancer	0.000534	0.000699	CcSEcCtD
Atropine—Vertigo—Methotrexate—urinary bladder cancer	0.000532	0.000697	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000527	0.00069	CcSEcCtD
Atropine—Nausea—Cisplatin—urinary bladder cancer	0.000524	0.000685	CcSEcCtD
Atropine—Vision blurred—Epirubicin—urinary bladder cancer	0.000523	0.000684	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000516	0.000676	CcSEcCtD
Atropine—Convulsion—Methotrexate—urinary bladder cancer	0.000513	0.000672	CcSEcCtD
Atropine—Vomiting—Etoposide—urinary bladder cancer	0.000513	0.000672	CcSEcCtD
Atropine—Erythema—Doxorubicin—urinary bladder cancer	0.000513	0.000672	CcSEcCtD
Atropine—Agitation—Epirubicin—urinary bladder cancer	0.00051	0.000667	CcSEcCtD
Atropine—Rash—Etoposide—urinary bladder cancer	0.000509	0.000667	CcSEcCtD
Atropine—Dermatitis—Etoposide—urinary bladder cancer	0.000509	0.000666	CcSEcCtD
Atropine—Headache—Etoposide—urinary bladder cancer	0.000506	0.000662	CcSEcCtD
Atropine—Chest pain—Methotrexate—urinary bladder cancer	0.000505	0.000661	CcSEcCtD
Atropine—Tension—Doxorubicin—urinary bladder cancer	0.000504	0.000659	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000503	0.000658	CcSEcCtD
Atropine—Nervousness—Doxorubicin—urinary bladder cancer	0.000498	0.000653	CcSEcCtD
Atropine—Vertigo—Epirubicin—urinary bladder cancer	0.000498	0.000652	CcSEcCtD
Atropine—Syncope—Epirubicin—urinary bladder cancer	0.000497	0.000651	CcSEcCtD
Atropine—Palpitations—Epirubicin—urinary bladder cancer	0.00049	0.000642	CcSEcCtD
Atropine—Confusional state—Methotrexate—urinary bladder cancer	0.000488	0.000639	CcSEcCtD
Atropine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000487	0.000638	CcSEcCtD
Atropine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000484	0.000633	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000484	0.000633	CcSEcCtD
Atropine—Convulsion—Epirubicin—urinary bladder cancer	0.000481	0.000629	CcSEcCtD
Atropine—Nausea—Etoposide—urinary bladder cancer	0.00048	0.000628	CcSEcCtD
Atropine—Chest pain—Epirubicin—urinary bladder cancer	0.000472	0.000618	CcSEcCtD
Atropine—Agitation—Doxorubicin—urinary bladder cancer	0.000472	0.000617	CcSEcCtD
Atropine—Anxiety—Epirubicin—urinary bladder cancer	0.000471	0.000616	CcSEcCtD
Atropine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000468	0.000612	CcSEcCtD
Atropine—Dry mouth—Epirubicin—urinary bladder cancer	0.000462	0.000605	CcSEcCtD
Atropine—Vertigo—Doxorubicin—urinary bladder cancer	0.000461	0.000604	CcSEcCtD
Atropine—Syncope—Doxorubicin—urinary bladder cancer	0.00046	0.000603	CcSEcCtD
Atropine—Confusional state—Epirubicin—urinary bladder cancer	0.000456	0.000598	CcSEcCtD
Atropine—Palpitations—Doxorubicin—urinary bladder cancer	0.000453	0.000594	CcSEcCtD
Atropine—Oedema—Epirubicin—urinary bladder cancer	0.000453	0.000593	CcSEcCtD
Atropine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000453	0.000593	CcSEcCtD
Atropine—Hypotension—Methotrexate—urinary bladder cancer	0.000452	0.000592	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000451	0.000591	CcSEcCtD
Atropine—Shock—Epirubicin—urinary bladder cancer	0.000445	0.000583	CcSEcCtD
Atropine—Convulsion—Doxorubicin—urinary bladder cancer	0.000445	0.000582	CcSEcCtD
Atropine—Tachycardia—Epirubicin—urinary bladder cancer	0.000442	0.000578	CcSEcCtD
Atropine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000438	0.000573	CcSEcCtD
Atropine—Insomnia—Methotrexate—urinary bladder cancer	0.000437	0.000573	CcSEcCtD
Atropine—Chest pain—Doxorubicin—urinary bladder cancer	0.000437	0.000572	CcSEcCtD
Atropine—Anxiety—Doxorubicin—urinary bladder cancer	0.000435	0.00057	CcSEcCtD
Atropine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000431	0.000565	CcSEcCtD
Atropine—Somnolence—Methotrexate—urinary bladder cancer	0.00043	0.000563	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000427	0.000559	CcSEcCtD
Atropine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000426	0.000557	CcSEcCtD
Atropine—Hypotension—Epirubicin—urinary bladder cancer	0.000423	0.000554	CcSEcCtD
Atropine—Confusional state—Doxorubicin—urinary bladder cancer	0.000422	0.000553	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000419	0.000548	CcSEcCtD
Atropine—Oedema—Doxorubicin—urinary bladder cancer	0.000419	0.000548	CcSEcCtD
Atropine—Fatigue—Methotrexate—urinary bladder cancer	0.000417	0.000546	CcSEcCtD
Atropine—Pain—Methotrexate—urinary bladder cancer	0.000414	0.000542	CcSEcCtD
Atropine—Shock—Doxorubicin—urinary bladder cancer	0.000412	0.00054	CcSEcCtD
Atropine—Insomnia—Epirubicin—urinary bladder cancer	0.000409	0.000536	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000409	0.000535	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000405	0.00053	CcSEcCtD
Atropine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000404	0.000528	CcSEcCtD
Atropine—Somnolence—Epirubicin—urinary bladder cancer	0.000402	0.000527	CcSEcCtD
Atropine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000399	0.000522	CcSEcCtD
Atropine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000398	0.000522	CcSEcCtD
Atropine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000396	0.000518	CcSEcCtD
Atropine—Hypotension—Doxorubicin—urinary bladder cancer	0.000391	0.000512	CcSEcCtD
Atropine—Fatigue—Epirubicin—urinary bladder cancer	0.00039	0.000511	CcSEcCtD
Atropine—Pain—Epirubicin—urinary bladder cancer	0.000387	0.000507	CcSEcCtD
Atropine—Constipation—Epirubicin—urinary bladder cancer	0.000387	0.000507	CcSEcCtD
Atropine—Urticaria—Methotrexate—urinary bladder cancer	0.000384	0.000503	CcSEcCtD
Atropine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000382	0.000501	CcSEcCtD
Atropine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000382	0.000501	CcSEcCtD
Atropine—Insomnia—Doxorubicin—urinary bladder cancer	0.000379	0.000496	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000373	0.000489	CcSEcCtD
Atropine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000373	0.000488	CcSEcCtD
Atropine—Somnolence—Doxorubicin—urinary bladder cancer	0.000372	0.000487	CcSEcCtD
Atropine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00037	0.000485	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000369	0.000483	CcSEcCtD
Atropine—Fatigue—Doxorubicin—urinary bladder cancer	0.000361	0.000473	CcSEcCtD
Atropine—Urticaria—Epirubicin—urinary bladder cancer	0.00036	0.000471	CcSEcCtD
Atropine—Constipation—Doxorubicin—urinary bladder cancer	0.000358	0.000469	CcSEcCtD
Atropine—Pain—Doxorubicin—urinary bladder cancer	0.000358	0.000469	CcSEcCtD
Atropine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000358	0.000469	CcSEcCtD
Atropine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000358	0.000469	CcSEcCtD
Atropine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000356	0.000467	CcSEcCtD
Atropine—Asthenia—Methotrexate—urinary bladder cancer	0.000347	0.000454	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000345	0.000452	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000342	0.000448	CcSEcCtD
Atropine—Pruritus—Methotrexate—urinary bladder cancer	0.000342	0.000448	CcSEcCtD
Atropine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000333	0.000437	CcSEcCtD
Atropine—Urticaria—Doxorubicin—urinary bladder cancer	0.000333	0.000436	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000331	0.000433	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000331	0.000433	CcSEcCtD
Atropine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000331	0.000433	CcSEcCtD
Atropine—Asthenia—Epirubicin—urinary bladder cancer	0.000325	0.000425	CcSEcCtD
Atropine—Pruritus—Epirubicin—urinary bladder cancer	0.00032	0.000419	CcSEcCtD
Atropine—Dizziness—Methotrexate—urinary bladder cancer	0.00032	0.000419	CcSEcCtD
Atropine—Diarrhoea—Epirubicin—urinary bladder cancer	0.00031	0.000405	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000309	0.000404	CcSEcCtD
Atropine—Vomiting—Methotrexate—urinary bladder cancer	0.000308	0.000403	CcSEcCtD
Atropine—Rash—Methotrexate—urinary bladder cancer	0.000305	0.000399	CcSEcCtD
Atropine—Dermatitis—Methotrexate—urinary bladder cancer	0.000305	0.000399	CcSEcCtD
Atropine—Headache—Methotrexate—urinary bladder cancer	0.000303	0.000397	CcSEcCtD
Atropine—Asthenia—Doxorubicin—urinary bladder cancer	0.0003	0.000393	CcSEcCtD
Atropine—Dizziness—Epirubicin—urinary bladder cancer	0.000299	0.000392	CcSEcCtD
Atropine—Pruritus—Doxorubicin—urinary bladder cancer	0.000296	0.000388	CcSEcCtD
Atropine—Vomiting—Epirubicin—urinary bladder cancer	0.000288	0.000377	CcSEcCtD
Atropine—Nausea—Methotrexate—urinary bladder cancer	0.000287	0.000376	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000287	0.000375	CcSEcCtD
Atropine—Rash—Epirubicin—urinary bladder cancer	0.000285	0.000374	CcSEcCtD
Atropine—Dermatitis—Epirubicin—urinary bladder cancer	0.000285	0.000373	CcSEcCtD
Atropine—Headache—Epirubicin—urinary bladder cancer	0.000284	0.000371	CcSEcCtD
Atropine—Dizziness—Doxorubicin—urinary bladder cancer	0.000277	0.000363	CcSEcCtD
Atropine—Nausea—Epirubicin—urinary bladder cancer	0.000269	0.000352	CcSEcCtD
Atropine—Vomiting—Doxorubicin—urinary bladder cancer	0.000266	0.000349	CcSEcCtD
Atropine—Rash—Doxorubicin—urinary bladder cancer	0.000264	0.000346	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000264	0.000345	CcSEcCtD
Atropine—Headache—Doxorubicin—urinary bladder cancer	0.000262	0.000344	CcSEcCtD
Atropine—Nausea—Doxorubicin—urinary bladder cancer	0.000249	0.000326	CcSEcCtD
